Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 22.90
+0.20 (0.88%)
At close: Mar 27, 2026
HKG:6826 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 208.32 | 420.45 | 416.12 | 180.47 | 352.23 |
Depreciation & Amortization | 200.43 | 203.86 | 197.86 | 200.89 | 159.95 |
Other Amortization | 6.33 | 1.37 | - | 3.33 | 2.89 |
Loss (Gain) From Sale of Assets | 0.2 | 0.02 | -0.59 | 0.51 | 0.37 |
Asset Writedown & Restructuring Costs | 167.46 | - | - | 46.07 | - |
Loss (Gain) From Sale of Investments | -4.54 | -25.92 | -2.3 | 7.78 | -0.02 |
Loss (Gain) on Equity Investments | - | -0.99 | -0.46 | -3.51 | -2.19 |
Stock-Based Compensation | - | 3 | 14.3 | 30.23 | - |
Provision & Write-off of Bad Debts | - | -2.23 | -1.97 | 15.52 | -3.18 |
Other Operating Activities | -58.44 | -93.7 | -61.7 | -66.5 | -191.69 |
Change in Accounts Receivable | -18.26 | -39.35 | 10.13 | -52.33 | -41.92 |
Change in Inventory | -50.13 | 5.32 | -48.42 | -138.86 | -28.63 |
Change in Accounts Payable | 83.68 | 62.62 | 43.48 | 35.44 | 32.35 |
Change in Other Net Operating Assets | - | 114.12 | 67.99 | -27.75 | 62.13 |
Operating Cash Flow | 490.97 | 648.57 | 634.45 | 231.3 | 342.29 |
Operating Cash Flow Growth | -24.30% | 2.23% | 174.30% | -32.43% | 30.61% |
Capital Expenditures | -186.94 | -364.18 | -265.6 | -309.21 | -270.88 |
Sale of Property, Plant & Equipment | 5.91 | 0.72 | 1.84 | 0.39 | 0.21 |
Cash Acquisitions | - | -17.58 | - | -2.94 | -83.28 |
Divestitures | 80.58 | - | - | 17.59 | - |
Sale (Purchase) of Intangibles | - | -1.31 | -1.63 | -7.94 | -1.22 |
Investment in Securities | 139.7 | 586.14 | -189.68 | -468.55 | 52.67 |
Other Investing Activities | 161.3 | 75.98 | 78.42 | 88.84 | 154.4 |
Investing Cash Flow | 200.55 | 282.28 | -376.65 | -681.82 | -148.09 |
Long-Term Debt Issued | 235.89 | 242 | 313.89 | 65.94 | 38.01 |
Long-Term Debt Repaid | -287.09 | -221.08 | -40.93 | -69.7 | -119.5 |
Net Debt Issued (Repaid) | -51.19 | 20.92 | 272.96 | -3.76 | -81.49 |
Issuance of Common Stock | - | 49.45 | 73.68 | - | - |
Repurchase of Common Stock | - | -175.35 | -269.98 | -147.67 | -44.91 |
Common Dividends Paid | -245.55 | -259.86 | -68.52 | -121.89 | -87.91 |
Other Financing Activities | -283.91 | -25.51 | -265.87 | -15.03 | -16.94 |
Financing Cash Flow | -580.66 | -390.35 | -257.73 | -288.35 | -231.25 |
Foreign Exchange Rate Adjustments | 4.63 | 3.08 | 10.05 | 14.17 | -6.94 |
Net Cash Flow | 115.49 | 543.59 | 10.12 | -724.7 | -43.99 |
Free Cash Flow | 304.04 | 284.39 | 368.85 | -77.91 | 71.41 |
Free Cash Flow Growth | 6.91% | -22.90% | - | - | -1.34% |
Free Cash Flow Margin | 12.29% | 10.61% | 14.00% | -3.70% | 4.08% |
Free Cash Flow Per Share | 1.31 | 1.22 | 1.55 | -0.23 | 0.21 |
Cash Interest Paid | - | 18.06 | 5.1 | 4.99 | 3 |
Cash Income Tax Paid | 274.29 | 115.59 | 88.19 | 43.72 | 70.22 |
Levered Free Cash Flow | 202.93 | 206.16 | 209.26 | -112.91 | -9.78 |
Unlevered Free Cash Flow | 202.93 | 217.44 | 213.82 | -108.16 | -6.68 |
Change in Working Capital | -28.78 | 142.71 | 73.19 | -183.49 | 23.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.